Literature DB >> 15504867

Molecular mechanisms of primary resistance to flucytosine in Candida albicans.

William W Hope1, Lydia Tabernero, David W Denning, Michael J Anderson.   

Abstract

Primary resistance in Candida albicans to flucytosine (5-FC) was investigated in 25 strains by identifying and sequencing the genes FCA1, FUR1, FCY21, and FCY22, which code for cytosine deaminase, uracil phosphoribosyltransferase (UPRT), and two purine-cytosine permeases, respectively. These proteins are involved in pyrimidine salvage and 5-FC metabolism. An association between a polymorphic nucleotide and resistance to 5-FC was found within FUR1 where the substitution of cytidylate for thymidylate at nucleotide position 301 results in the replacement of arginine with cysteine at amino acid position 101 in UPRT. Isolates that are homozygous for this mutation display increased levels of resistance to 5-FC, whereas heterozygous isolates have reduced susceptibility. Three-dimensional protein modeling of UPRT suggests that the Arg101Cys mutation disturbs the quaternary structure of the enzyme, which is postulated to compromise optimal enzyme activity. A single resistant isolate, lacking the above polymorphism in FUR1, has a homozygous polymorphism in FCA1 that results in a glycine-to-aspartate substitution at position 28 in cytosine deaminase.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15504867      PMCID: PMC525410          DOI: 10.1128/AAC.48.11.4377-4386.2004

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  25 in total

1.  Primary resistance to flucytosine among clinical isolates of Candida spp.

Authors:  F Barchiesi; D Arzeni; F Caselli; G Scalise
Journal:  J Antimicrob Chemother       Date:  2000-03       Impact factor: 5.790

2.  Baker's yeast UMP:pyrophosphate phosphoribosyltransferase. Purification, enzymatic and kinetic properties.

Authors:  P Natalini; S Ruggieri; I Santarelli; A Vita; G Magni
Journal:  J Biol Chem       Date:  1979-03-10       Impact factor: 5.157

3.  In vitro activities of 5-fluorocytosine against 8,803 clinical isolates of Candida spp.: global assessment of primary resistance using National Committee for Clinical Laboratory Standards susceptibility testing methods.

Authors:  M A Pfaller; S A Messer; L Boyken; H Huynh; R J Hollis; D J Diekema
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

4.  The structural mechanism of GTP stabilized oligomerization and catalytic activation of the Toxoplasma gondii uracil phosphoribosyltransferase.

Authors:  Maria A Schumacher; Caleb J Bashor; Minsun Hong Song; Kanao Otsu; Shuren Zhu; Ronald J Parry; Buddy Ullman; Richard G Brennan
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-02       Impact factor: 11.205

5.  Tpn1p, the plasma membrane vitamin B6 transporter of Saccharomyces cerevisiae.

Authors:  Jürgen Stolz; Martin Vielreicher
Journal:  J Biol Chem       Date:  2003-03-20       Impact factor: 5.157

6.  The influence of 5-fluorocytosine on nucleic acid synthesis in Candida albicans, Cryptococcus neoformans, and Aspergillus fumigatus.

Authors:  A Polak; W H Wain
Journal:  Chemotherapy       Date:  1977       Impact factor: 2.544

7.  Genetic and physiological aspects of resistance to 5-fluoropyrimidines in Saccharomyces cerevisiae.

Authors:  R Jund; F Lacroute
Journal:  J Bacteriol       Date:  1970-06       Impact factor: 3.490

8.  Clade-specific flucytosine resistance is due to a single nucleotide change in the FUR1 gene of Candida albicans.

Authors:  Andrew R Dodgson; Kirsty J Dodgson; Claude Pujol; Michael A Pfaller; David R Soll
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191

9.  Flucytosine resistance is restricted to a single genetic clade of Candida albicans.

Authors:  Claude Pujol; Michael A Pfaller; David R Soll
Journal:  Antimicrob Agents Chemother       Date:  2004-01       Impact factor: 5.191

10.  In vitro studies of 5-fluorocytosine resistance in Candida albicans and Torulopsis glabrata.

Authors:  S Normark; J Schönebeck
Journal:  Antimicrob Agents Chemother       Date:  1972-09       Impact factor: 5.191

View more
  48 in total

Review 1.  Progress in antifungal susceptibility testing of Candida spp. by use of Clinical and Laboratory Standards Institute broth microdilution methods, 2010 to 2012.

Authors:  M A Pfaller; D J Diekema
Journal:  J Clin Microbiol       Date:  2012-06-27       Impact factor: 5.948

2.  Chromatin-mediated Candida albicans virulence.

Authors:  Jessica Lopes da Rosa; Paul D Kaufman
Journal:  Biochim Biophys Acta       Date:  2011-08-24

Review 3.  Mechanisms of Antifungal Drug Resistance.

Authors:  Leah E Cowen; Dominique Sanglard; Susan J Howard; P David Rogers; David S Perlin
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-10       Impact factor: 6.915

4.  The Ca-loop in thymidylate kinase is critical for growth and contributes to pyrimidine drug sensitivity of Candida albicans.

Authors:  Chang-Yu Huang; Yee-Chun Chen; Betty A Wu-Hsieh; Jim-Min Fang; Zee-Fen Chang
Journal:  J Biol Chem       Date:  2019-05-31       Impact factor: 5.157

5.  Novel 5-flucytosine-resistant clade of Candida dubliniensis from Saudi Arabia and Egypt identified by Cd25 fingerprinting.

Authors:  Asmaa Al Mosaid; Derek J Sullivan; Itzhack Polacheck; Faisal A Shaheen; Osama Soliman; Saleh Al Hedaithy; Sahar Al Thawad; Motaz Kabadaya; David C Coleman
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

Review 6.  Targeting efflux pumps to overcome antifungal drug resistance.

Authors:  Ann R Holmes; Tony S Cardno; J Jacob Strouse; Irena Ivnitski-Steele; Mikhail V Keniya; Kurt Lackovic; Brian C Monk; Larry A Sklar; Richard D Cannon
Journal:  Future Med Chem       Date:  2016-07-27       Impact factor: 3.808

7.  Inactivation of the FCY2 gene encoding purine-cytosine permease promotes cross-resistance to flucytosine and fluconazole in Candida lusitaniae.

Authors:  Florence Chapeland-Leclerc; Julien Bouchoux; Abdelhak Goumar; Christiane Chastin; Jean Villard; Thierry Noël
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

Review 8.  Mechanisms of Candida biofilm drug resistance.

Authors:  Heather T Taff; Kaitlin F Mitchell; Jessica A Edward; David R Andes
Journal:  Future Microbiol       Date:  2013-10       Impact factor: 3.165

9.  Population structure and properties of Candida albicans, as determined by multilocus sequence typing.

Authors:  Arianna Tavanti; Amanda D Davidson; Mark J Fordyce; Neil A R Gow; Martin C J Maiden; Frank C Odds
Journal:  J Clin Microbiol       Date:  2005-11       Impact factor: 5.948

10.  A Ser29Leu substitution in the cytosine deaminase Fca1p is responsible for clade-specific flucytosine resistance in Candida dubliniensis.

Authors:  Brenda A McManus; Gary P Moran; Judy A Higgins; Derek J Sullivan; David C Coleman
Journal:  Antimicrob Agents Chemother       Date:  2009-08-24       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.